Skip to main content

Jasper Therapeutics, Inc. (JSPR)

NASDAQ: JSPR · IEX Real-Time Price · USD
13.92
-0.28 (-1.97%)
After-hours:Oct 20, 2021 7:32 PM EDT
14.20
0.62 (4.57%)
At close: Oct 20, 4:00 PM
Market Cap518.59M
Revenue (ttm)n/a
Net Income (ttm)-49.59M
Shares Out7.46M
EPS (ttm)-3.84
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,055,968
Open14.39
Previous Close13.58
Day's Range13.61 - 14.55
52-Week Range7.11 - 18.88
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About JSPR

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

IndustryBiotechnology
Founded2018
Employees24
Stock ExchangeNASDAQ
Ticker SymbolJSPR
Full Company Profile

Financial Performance

Financial Statements

News

2 Biotech Stocks Poised for Jaw-Dropping Growth

These two tiny drugmakers could make early shareholders wealthy.

Other symbols:NRXP
3 days ago - The Motley Fool

Why Jasper Therapeutics Stock Is Falling Today

Jasper Therapeutics Inc (NASDAQ: JSPR) is trading lower Thursday amid profit taking after the stock rallied roughly 120% on Wednesday. Jasper Therapeutics surged higher Wednesday after Oppenheimer analy...

6 days ago - Benzinga

Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving Today

There's loads of hot penny stocks worth checking in on today and we're taking a look at what some of the top movers are doing! The post Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving To...

1 week ago - InvestorPlace

JSPR Stock: The Bullish Call That Has Biotech Play Jasper Therapeutics Rocketing 105% Today

Jasper Therapeutics (JSPR) stock is taking off on Wednesday thanks to a new bullish call from Oppenheimer analyst Jay Olson. The post JSPR Stock: The Bullish Call That Has Biotech Play Jasper Therapeuti...

1 week ago - InvestorPlace

Why Jasper Therapeutics Stock Is Jumping Today

A Wall Street investment bank just started following the company with a very upbeat outlook.

1 week ago - The Motley Fool

Why Jasper Therapeutics Stock Is Soaring Today

Jasper Therapeutics Inc (NASDAQ: JSPR) is surging higher Wednesday after Oppenheimer analyst Jay Olson initiated coverage on the stock with an Outperform rating and announced a price target of $21. The ...

1 week ago - Benzinga

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination w...

3 weeks ago - Business Wire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Amplitude Healthcare Acquisition Corp. - ...

NEW YORK, June 8, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...

4 months ago - PRNewsWire

'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines

Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs.

Other symbols:LOKB
5 months ago - Benzinga

Jasper Therapeutics To List On NASDAQ Via SPAC Reverse Merger

Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in a $100 million deal.

5 months ago - Benzinga

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Lead...

REDWOOD CITY, Calif., & NEW YORK--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation...

5 months ago - Business Wire